 All patients with unresectable or metastatic soft tissue sarcoma STS: leiomyosarcoma, liposarcoma, fibrosarcoma, and malignant fibrous histiocytoma MFH seen at the Moffitt Cancer Center will be screened for eligibility to be enrolled in the study. 